Related Experiment Videos
Physicochemical characteristics of ferric adriamycin complexes
Cancer Chemotherapy and Pharmacology
|January 1, 1984
Summary
Iron and adriamycin form complexes that create colloidal and flocculant mixtures. This interaction, observed in quelamycin, explains the drug
Area of Science:
- Pharmaceutical Chemistry
- Materials Science
- Drug Delivery Systems
Background:
- Ferric ions (Fe3+) and the chemotherapy drug adriamycin interact in solution.
- These interactions can lead to the formation of colloidal and flocculant mixtures.
- Understanding these interactions is crucial for drug formulation and efficacy.
Purpose of the Study:
- To investigate the complex formation between ferric ions and adriamycin.
- To characterize the resulting colloidal and flocculant mixtures.
- To elucidate the implications of these complexes on drug toxicity and pharmacology.
Main Methods:
- Spectrophotometry to detect colloid formation at 600 nm.
- Dilution experiments.
- Ultracentrifugation, titration, and filtration techniques.
- pH and time-dependent phase transition analysis.
Main Results:
- High concentrations of ferric ions and adriamycin form complexes with absorption at 600 nm, indicating colloid formation.
- Evidence suggests a pH and time-sensitive phase transition occurs, yielding flocculated adriamycin.
- The preparation 'quelamycin' consists of flocculated iron-adriamycin complexes.
Conclusions:
- The toxic and pharmacologic effects of quelamycin are attributed to its flocculated iron-adriamycin composition.
- Utilizing colloidal preparations of reactive drugs may mitigate acute toxicity.
- Colloidal drug formulations could enable slower, controlled drug release.